Cargando…
Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and its incidence is expected to increase. Despite tremendous efforts to understand its underlying biological mechanisms, MDD pathophysiology remains elusive and pharmacotherapy outcomes are still far from ideal. L...
Autores principales: | Inserra, Antonio, Mastronardi, Claudio Alberto, Rogers, Geraint, Licinio, Julio, Wong, Ma-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505498/ https://www.ncbi.nlm.nih.gov/pubmed/30306457 http://dx.doi.org/10.1007/s12035-018-1359-3 |
Ejemplares similares
-
Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease
por: Bernardazzi, Claudio, et al.
Publicado: (2016) -
Neuroimmunomodulation
por: Bharucha, Stephen B.
Publicado: (1988) -
Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021) -
cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
por: Reierson, Gillian W, et al.
Publicado: (2011) -
Neuroimmunomodulation by estrogen in health and disease
por: Priyanka, Hannah P, et al.
Publicado: (2020)